Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial
Scholary Output:
Contribution to journal
Article
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
UndefinedJournal (Volume, Issue Number)
MedicinePublication milestones
- Published - 2004
Publication status
Published - 2004
ISSN
1357-3039Publication IDs
- ORCID: /0000-0001-9335-0082/work/52030072
Publication metrics
Metrics
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
